High Beclin-1 and ARIDIA expression are strongly associated with poor prognosis in ICC patients, and thus Beclin-1 and ARID1A should be simultaneously considered as potential prognostic biomarkers for ICC patients. The gene discussed is ARID1A; the disease is intrahepatic cholangiocarcinoma.